Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes

Ensuring high vaccination and even booster vaccination coverage is critical in preventing severe Coronavirus Disease 2019 (COVID-19). Among the various COVID-19 vaccines currently in use, the mRNA vaccines have shown remarkable effectiveness. However, systemic adverse events (AEs), such as postvacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Syenina, Ayesa, Gan, Esther S., Toh, Justin Z. N., de Alwis, Ruklanthi, Lin, Lowell Z., Tham, Christine Y. L., Yee, Jia Xin, Leong, Yan Shan, Sam, Huizhen, Cheong, Charlene, Teh, Yii Ean, Wee, Ian L. E., Ng, Dorothy H. L., Chan, Kuan Rong, Sim, Jean X. Y., Kalimuddin, Shirin, Ong, Eugenia Z., Low, Jenny G., Ooi, Eng Eong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154185/
https://www.ncbi.nlm.nih.gov/pubmed/35639676
http://dx.doi.org/10.1371/journal.pbio.3001643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154185/
https://www.ncbi.nlm.nih.gov/pubmed/35639676
http://dx.doi.org/10.1371/journal.pbio.3001643

Ejemplares similares